SCHEMBL42640

SCHEMBL42640

[CH2]/C=C/C[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14991021 1.00
SCHEMBL42641 1.00
SCHEMBL1114333 0.78
SCHEMBL1114332 0.78
SCHEMBL1541877 0.78
SCHEMBL1541875 0.78
SCHEMBL43592 0.75
SCHEMBL11264582 0.75
SCHEMBL43591 0.75
SCHEMBL1541959 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024143452-A1 3-METHYL-1-BUTENE-BASED POLYMER, MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION, PELLET, AND MOLDED ITEM 株式会社クラレ 2024-07-04 WO disclosed
US-12024595-B2 Polymer composition BASF SE (DE) 2024-07-02 US disclosed
WO-2024112546-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-30 WO disclosed
WO-2024112545-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-30 WO disclosed
US-20240174664-A1 BICYCLIC AMINES AS CDK2 INHIBITORS INCYTE CORPORATION 2024-05-30 US disclosed
WO-2024112543-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-30 WO disclosed
WO-2024112544-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-30 WO disclosed
WO-2024107892-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-23 WO disclosed
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 WO disclosed
US-11981671-B2 Bicyclic pyrazolyl amines as CDK2 inhibitors INCYTE CORPORATION (US) 2024-05-14 US disclosed
WO-1997043279-A1 2,4-DIAMINOPYRIMIDINE DERIVATES AS DOPAMINE D4 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1997-11-20 WO disclosed
WO-1997002322-A1 POLYSILANES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1997-01-23 WO disclosed
EP-0719289-A1 GAS PHASE POLYMERIZATION OF OLEFINS THE DOW CHEMICAL COMPANY (US) 1996-07-03 EP disclosed
WO-1995007942-A1 GAS PHASE POLYMERIZATION OF OLEFINS THE DOW CHEMICAL COMPANY (US) 1995-03-23 WO disclosed
US-5003074-A N-fluorinated sulfonamides CIBA-GEIGY CORPORATION (US) 1991-03-26 US disclosed
US-4451462-A Method of treating inflammation and pain using heteramino benzofurans CIBA-GEIGY CORPORATION (US) 1984-05-29 US disclosed
US-4426380-A ANTIINFLAMMATORY, ANALGESIC, SUNSCREEN CIBA-GEIGY CORPORATION (US) 1984-01-17 US disclosed
US-4181810-A FROM THE 2-SUBSTITUTED ETHANAL AND FORMALDEHYDE USING AN ACID ION EXCHANGER; HYDROGENATION OF REACTION PRODUCT BAYER AKTIENGESELLSCHAFT (DE) 1980-01-01 US disclosed
US-4161476-A α-Halo-2-oxo-1-azetidinemethane-carboxylic acid compounds CIBA-GEIGY CORPORATION (US) 1979-07-17 US disclosed
US-4052408-A OXYACETIC ACID COMPOUNDS AND PROCESS FOR THEIR MANUFACTURE CIBA-GEIGY CORPORATION (US) 1977-10-04 US disclosed